Discover
ICCC
ImmuCell Corporation
11.00
2 x 7.88
2 x 13.24
bid
ask
+
0.95
9.45%
2 @ 04:00 PM
11.01 +0.01 (0.09%)
| Ytd | 78.86% | |
| 1y | 66.16% |
10.19
day range
11.16
4.52
52 week range
11.16
| Open | 10.19 | Prev Close | 10.05 | Low | 10.19 | High | 11.16 | Mkt Cap | 99.51M |
| Vol | 56.12K | Avg Vol | 29.82K | EPS | -0.07 | P/E | N/A | Forward P/E | -42.82 |
| Beta | 0.57 | Short Ratio | 0.23 | Inst. Own | 14.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 9.32 | 200-d Avg | 6.99 | 1yr Est | 14.00 |
| Income Statement | |||
| Total Revenue | 10.36M | ||
| Revenues (USD) | 10.36M | ||
| Cost of Revenue | 5.70M | ||
| Gross Profit | 4.66M | ||
| Operating Expenses | 2.69M | ||
| Research and Development Expense | 317.69K | ||
| Selling, General and Administrative Expense | 2.37M | ||
| Operating Income | 1.97M | ||
| Income Tax Expense | 12.52K | ||
| Net Income | 1.94M | ||
| Net Income Common Stock | 1.94M | ||
| Net Income Common Stock (USD) | 1.94M | ||
| Consolidated Income | 1.94M | ||
| Earnings per Basic Share | 0.21 | ||
| Earnings per Basic Share (USD) | 0.21 | ||
| Earnings per Diluted Share | 0.21 | ||
| Earning Before Interest & Taxes (EBIT) | 1.95M | ||
| Earning Before Interest & Taxes (USD) | 1.95M | ||
| Weighted Average Shares | 9.05M | ||
| Weighted Average Shares Diluted | 9.05M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.81M | ||
| Cash and Equivalents (USD) | 6.81M | ||
| Trade and Non-Trade Receivables | 2.69M | ||
| Current Assets | 18.86M | ||
| Property, Plant & Equipment Net | 25.12M | ||
| Total Assets | 44.11M | ||
| Debt Current | 1.72M | ||
| Total Debt | 12.78M | ||
| Current Liabilities | 3.91M | ||
| Debt Non-Current | 11.06M | ||
| Total Liabilities | 14.97M | ||
| Accumulated Retained Earnings (Deficit) | -13.26M | ||
| Shareholders Equity | 29.14M | ||
| Shareholders Equity (USD) | 29.14M | ||
| Assets Non-Current | 25.25M | ||
| Total Debt (USD) | 12.78M | ||
| Goodwill and Intangible Assets | 95.56K | ||
| Inventory | 8.67M | ||
| Liabilities Non-Current | 11.06M | ||
| Trade and Non-Trade Payables | 2.20M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 528.29K | ||
| Net Cash Flow from Financing | -399.99K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.01M | ||
| Capital Expenditure | -167.23K | ||
| Issuance (Purchase) of Equity Shares | 4.00 | ||
| Issuance (Repayment) of Debt Securities | -400.00K | ||
| Net Cash Flow from Investing | -167.23K | ||
| Net Cash Flow from Operations | 3.57M | ||
| Share Based Compensation | 137.95K | ||